-
A world-leader in GPCR medicine design and development
-
Platform technology -
StaR® proteins and structures
Patent-protected StaR® stabilized receptor technology is our competitive advantage, enabling us to explore untapped opportunities in GPCRs
-
Drug discovery – SBDD Structure-Based Drug Design
New techniques and collaborations driving rapid throughput from hit to high-value drug candidates
-
Development pipeline – targeting therapeutic areas of need
Extensive pipeline of partnered and in-house development programs across Neurology, Immuno-oncology, Gastroenterology, Inflammation and Rare/Speciality indications